Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harpoon Therapeutics
Biotech
Daiichi pays Merck $170M to form lung cancer T-cell engager pact
Merck has quickly recouped some of the costs of its Harpoon buyout, pulling in $170 million by incorporating the lead candidate into its Daiichi deal.
Nick Paul Taylor
Aug 6, 2024 8:17am
Biopharma M&A more than doubled in Q1 compared to a year ago
Apr 18, 2024 9:46am
Merck inks $680M Harpoon buyout to challenge Amgen
Jan 8, 2024 8:41am
AbbVie drops Harpoon’s BCMA drug, ending dream of $200M payday
Sep 14, 2023 10:21am